Patent · US Active

Histidyl-tRNA synthetases for treating autoimmune and inflammatory diseases

US8835387B2 · kind B2 · utility

14Cited by

43References

30Claims

0Family size

Assignees

aTyr Pharma, Inc. · US
Pangu BioPharma Limited · CN

Inventors

Kyle P. Chiang · Irvine, US
Elisabeth Gardiner · San Diego, US
Ching-Fun Lau · Hong Kong, CN
Wing-Sze Lo · Hong Kong, CN
Jeffrey Greve · Branford, US
Melissa Ashlock · Rochester, US
John D. Mendlein · Encinitas, US

Key dates

Filing date	Feb 15, 2013
Grant date	Sep 16, 2014
Priority date	—
Expiry date	Feb 15, 2033

Classification

Technology area (CPC Y)Emerging Cross-Sectional Technologies
CPC primaryY02A50/30
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present invention relates generally to compositions and methods comprising histidyl-tRNA synthetase polypeptides or other specific blocking agents for the treatment autoimmune diseases and other inflammatory diseases, including those related to Jo-1 antibodies.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.